Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shivom is a health-technology company that utilizes blockchain and genomic sequencing to build a decentralized data marketplace for precision medicine. The platform enables individuals to own and control their genomic data while providing researchers with a secure, transparent way to access large-scale datasets for clinical studies. Shivom's primary goal is to bridge the gap between data donors and the pharmaceutical industry to accelerate drug discovery and improve healthcare outcomes globally. The company focuses on creating a diverse genomic database, particularly including underrepresented populations, to enhance the accuracy of medical research. By leveraging distributed ledger technology, Shivom ensures data privacy and security for all participants in the ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shivom.